interferon lambda 1
| UniProt | Protein Name |
|---|---|
| Q8IU54 |
|
| A0A7R8C391 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| negative regulation of type 2 immune response | ||
| receptor signaling pathway via JAK-STAT | ||
| negative regulation of cell population proliferation | ||
| negative regulation of interleukin-13 production | ||
| negative regulation of interleukin-5 production |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular space | ||
| interleukin-28 receptor complex |
| GO Term | Evidence Code | PMID |
|---|---|---|
| signaling receptor binding | ||
| signaling receptor binding | ||
| cytokine activity | ||
| interleukin-28 receptor binding |
| Gene Ontology |
|---|
| cytokine activity |
| defense response to virus |
| positive regulation of immune response |
| receptor signaling pathway via JAK-STAT |
| signaling receptor binding |
| InterPro |
|---|
| Interferon lambda superfamily |
| Interferon lambda |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0080600 | COVID-19 | |
| DOID:12206 | dengue hemorrhagic fever | |
| DOID:1883 | hepatitis C | |
| DOID:684 | hepatocellular carcinoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026